A few studies have reported that total serum ACE2 levels are elevated in severe (20) and in critically ill COVID-19 patients (21), with higher levels of serum ACE2 occurring in severe cases (22) and in non-survivor infected individuals (23). Here, ACE2 is linked to COVID-19.